MMedXYNews
Ask AIHomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY News/Ophthalmology

Section

Ophthalmology

298 articles

Ask AI
All specialtiesOphthalmologynewsClinical UpdatesCardiologyOncology

Latest updates

news

Two-Year Outcomes of Intravitreal Pegcetacoplan in Managing Geographic Atrophy: Real-World Clinical Experience

Intravitreal pegcetacoplan significantly slowed geographic atrophy progression by 41% over two years, maintaining efficacy in clinical practice for AMD patients, with stable visual acuity decline and manageable safety.

Sep 17, 2026
news

Long-Term Visual Field Outcomes in Eyes with Failed Trabeculectomy: Evaluating Repeat Trabeculectomy versus Ahmed Glaucoma Valve Implantation

This retrospective cohort study compares visual field progression after repeat trabeculectomy versus Ahmed glaucoma valve implantation in eyes with prior trabeculectomy failure, revealing similar postoperative visual outcomes but greater in

Sep 17, 2026
news

Stratifying Risk for Further Retinal Intervention After Laser Retinopexy: The Impact of Cumulative Clinical Factors

A novel, cumulative risk factor approach identifies patients at increased risk for additional retinal intervention after laser retinopexy for retinal tears, improving surveillance and management strategies.

Sep 15, 2026
Diabetes & Endocrinology

Common Anti-Inflammatory Drugs Linked to Lower Risk of Vision-Threatening Diabetic Retinopathy in Type 2 Diabetes

A large retrospective cohort study suggests that cetirizine, ibuprofen, and prednisone use in adults with type 2 diabetes is associated with significantly reduced incidence of diabetic macular edema and proliferative diabetic retinopathy, h

Sep 14, 2026Sign in to read
news

Evolving Microbial Landscape and Clinical Profiles in Postcataract Endophthalmitis: Insights from a 23-Year Retrospective Cohort Study

This study reveals significant shifts in the bacterial spectrum, antimicrobial resistance, and clinical presentation of acute postcataract endophthalmitis over 23 years, underscoring the need for updated surveillance and tailored treatment

Sep 13, 2026
news

Widening the Spectrum of Disease Expression due to Heterozygous Variants in EFEMP1

A case series delineating a novel EFEMP1 variant, p.Arg140Trp, associated with late-onset peripheral retinal degeneration distinct from classic DHRD/ML, highlighting rod dysfunction precedes structural changes.

Sep 13, 2026
Diabetes & Endocrinology

Why Metrics Matter in Thyroid Eye Disease: Exploring the Innovate TED Initiative

This article examines the critical need for refined clinical metrics in thyroid eye disease (TED) to better evaluate new targeted therapies, highlighting the Innovate TED Initiative’s efforts to develop and validate comprehensive outcome me

Sep 13, 2026
news

Differential Impact of Reticular Pseudodrusen Subtypes on Retinal Sensitivity in Intermediate Age-Related Macular Degeneration

This study elucidates how ribbon-type reticular pseudodrusen, especially when coexisting with soft drusen, significantly impair retinal sensitivity in intermediate AMD, highlighting the importance of lesion phenotype in functional risk asse

Sep 12, 2026
Dermatology

Unveiling Dupilumab-Associated Ocular Surface Disease in Atopic Dermatitis: Insights from a Large Prospective BioDay Cohort

This study reveals that 30.7% of atopic dermatitis patients treated with dupilumab develop ocular surface disease, despite prevalent ocular symptoms at baseline and increased ophthalmic treatment during therapy, linked to reduced conjunctiv

Sep 12, 2026Sign in to read
Diabetes & Endocrinology

Satralizumab Demonstrates Promising Efficacy and Safety in Treating Thyroid Eye Disease: Insights from Phase 3 SatraGO-1 and SatraGO-2 Trials

Phase 3 trials show satralizumab significantly improves proptosis, inflammation, and diplopia in thyroid eye disease with a favorable safety profile, marking a new therapeutic option targeting the IL-6 receptor pathway.

Sep 12, 2026Sign in to read
Diabetes & Endocrinology

Real-World Eligibility of Diabetic Macular Edema Patients for Anti-VEGF Trials: Implications for Clinical Practice and Health Equity

A significant proportion of real-world diabetic macular edema patients are excluded from clinical trials of anti-VEGF therapy due to stringent systemic criteria, disproportionately affecting racial minorities. This study highlights the need

Sep 10, 2026
Clinical Updates

Cumulative Atopic Disease Burden and Keratoconus: Insights from Large-Scale Cross-Sectional and Longitudinal Analyses

This review synthesizes evidence linking cumulative atopic diseases—including asthma, atopic dermatitis, and allergic rhinitis—to keratoconus risk, highlighting a dose-dependent association and the role of healthcare utilization in case asc

Sep 9, 2026
Diabetes & Endocrinology

Sex-Specific Associations Between Adiposity and Dry Eye Disease: Insights from a Large UK Biobank Study

Central obesity in women and high overall body fat in men are linked to increased odds of dry eye disease, with distinct metabolic pathways implicated, based on a retrospective analysis of over 480,000 UK Biobank participants.

Sep 9, 2026
Clinical Updates

Event-Based Progression Detection in Glaucoma: Integrating OCT, OCT Angiography, and Visual Field Metrics

This review synthesizes recent evidence on event-based progression detection in glaucoma, highlighting that OCTA vessel density may identify progression earlier than structural OCT or visual field testing, with important implications for cl

Sep 9, 2026
Clinical Updates

Longitudinal Trajectories of 3-Dimensional Eye Shape and Pathological Sequelae in High Myopia: Implications for Personalized Surveillance

This review synthesizes longitudinal evidence on 3D eye shape remodeling in high myopia, linking distinct morphologic trajectories to sight-threatening outcomes and supporting individualized risk stratification beyond axial length alone.

Sep 9, 2026
Clinical Updates

Safety and Effects of Gildeuretinol Acetate on Retinal Atrophic Lesions in Stargardt Disease: Insights from the TEASE-1 Randomized Clinical Trial

This review synthesizes evidence from the TEASE-1 trial and related studies on gildeuretinol acetate, highlighting its safety profile and modest efficacy in slowing retinal atrophic lesion growth in Stargardt disease over 24 months.

Sep 7, 2026Sign in to read
news

Prevalence and Characteristics of Null Studies in Ophthalmology: A Comprehensive Analysis from 2014 to 2025

A large-scale PubMed analysis reveals that one in five ophthalmology studies report null primary outcomes, with declining prevalence over time and notable differences in funding, design, and journal impact between null and positive studies.

Sep 5, 2026
Diabetes & Endocrinology

Impact of Neighborhood Socioeconomic Deprivation on Diabetic Retinopathy Screening Adherence in Medicare Beneficiaries

Increasing neighborhood socioeconomic deprivation is associated with reduced adherence to annual diabetic retinopathy screening among Medicare patients, highlighting disparities in preventive eye care.

Aug 31, 2026Sign in to read
news

Long-Term Incidence and Risk Factors for Glaucoma: Insights from the Gangnam Eye Cohort Study

A 10-year Korean cohort study reveals that retinal arteriosclerosis, intraocular pressure, age, serum uric acid, and cholesterol levels significantly increase the risk of structural glaucoma conversion.

Aug 31, 2026Sign in to read
Clinical Updates

Digital Defocus Vision Training Using Virtual Reality for Myopia Control: Current Evidence and Clinical Implications

Virtual reality-based digital defocus vision training (DDVT) shows promise as a home-based adjunct to slow myopia progression in children, with randomized trial data demonstrating modest reductions in axial length and refractive error progr

Aug 31, 2026
Previous
5 / 15
1…34567…15
Next

Go deeper with MedXY AI

Explore the evidence behind the news.

Ask AI
MedXY briefing

Stay informed

Medical news and research updates, delivered to your inbox.